| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/25/2013 | CA2627598C Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2542434C Combination of flupirtine and tolperisone or eperisone for the treatment of painful conditions |
| 06/25/2013 | CA2506704C Peritoneal dialysis method |
| 06/25/2013 | CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/25/2013 | CA2458798C Method for reducing hypertension and heart failure |
| 06/25/2013 | CA2444894C Sustained release drug delivery system containing codrugs |
| 06/25/2013 | CA2428744C Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| 06/20/2013 | WO2013090552A1 Compositions and methods for reducing ctl exhaustion |
| 06/20/2013 | WO2013090321A1 Vasoconstrictor for use in the treatment of abnormal uterine bleeding |
| 06/20/2013 | WO2013090278A2 Intranasal dexmedetomidine compositions and methods of use thereof |
| 06/20/2013 | WO2013090196A1 Combinations of azilsartan and chlorthalidone for treating hypertension black patients |
| 06/20/2013 | WO2013089140A1 Method for producing antimicrobial composition |
| 06/20/2013 | WO2013088243A1 Compositions of buprenorphine and mu-opioid receptor antagonists |
| 06/20/2013 | WO2013088242A1 Samidorphan (alks 33) in combination with opioid agonists |
| 06/20/2013 | WO2013088161A1 Sublingual administration of statins |
| 06/20/2013 | WO2013087936A1 Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders |
| 06/20/2013 | WO2013086574A1 Method of treatment |
| 06/20/2013 | WO2013055874A3 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 06/20/2013 | US20130158589 Methods And Kits For Treating Lacerations And Puncture Wounds Using Inverse Thermosensitive Polymers |
| 06/20/2013 | US20130158510 System and method for treatment of hemorrhagic stroke |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158124 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/20/2013 | US20130158111 Compositions and Methods for Depleting Mutant p53 |
| 06/20/2013 | US20130158109 Rhenium complexes and their pharmaceutical use |
| 06/20/2013 | US20130158092 New Oral Formulation |
| 06/20/2013 | US20130158089 MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR |
| 06/20/2013 | US20130158086 Methods of treatment and pharmaceutical composition |
| 06/20/2013 | US20130158085 Methods of treatment and pharmaceutical composition |
| 06/20/2013 | US20130158078 Heterocyclic Sulfone MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 06/20/2013 | US20130158076 Methylene Urea Derivatives |
| 06/20/2013 | US20130158072 Kappa opioid receptor binding ligands |
| 06/20/2013 | US20130158067 TRPV1 Antagonists |
| 06/20/2013 | US20130158060 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 06/20/2013 | US20130158036 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 06/20/2013 | US20130158027 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 06/20/2013 | US20130158020 Indazole derivatives useful as erk inhibitors |
| 06/20/2013 | US20130157994 High-purity texaphyrin metal complexes |
| 06/20/2013 | US20130157989 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 06/20/2013 | US20130157988 Substituted androst-4-ene diones |
| 06/20/2013 | US20130157987 1-deoxy analogs of 1,25-dihydroxyvitamin d3 compounds |
| 06/20/2013 | US20130157986 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 06/20/2013 | US20130157985 Pain relief compositions, manufacture and uses |
| 06/20/2013 | US20130157981 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 06/20/2013 | US20130157980 Substituted indole derivatives |
| 06/20/2013 | US20130157979 Phosphate esters of gyrase and topoisomerase inhibitors |
| 06/20/2013 | US20130157978 Preparation for the prevention and/or treatment of vascular disorders |
| 06/20/2013 | US20130157974 Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s) |
| 06/20/2013 | US20130157973 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/20/2013 | US20130157970 Novel glycoside compounds |
| 06/20/2013 | US20130157965 Prevention and Treatment of Oxidative Stress Disorders by Glutathione and Phase II Detoxification Enzymes |
| 06/20/2013 | US20130157961 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use |
| 06/20/2013 | US20130157960 Novel auristatin derivatives and use thereof |
| 06/20/2013 | US20130157949 Novel Peptides for Wound Healing |
| 06/20/2013 | US20130157945 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |
| 06/20/2013 | US20130157941 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 06/20/2013 | US20130157940 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/20/2013 | US20130157935 Glucagon analogues |
| 06/20/2013 | US20130157929 Glucagon analogues |
| 06/20/2013 | US20130157928 Nociceptin mimetics |
| 06/20/2013 | US20130157925 Compositions and methods for the treatment of cancer |
| 06/20/2013 | US20130157924 Reducing transmission of sexually transmitted infections |
| 06/20/2013 | US20130157339 Stabilized protease composition |
| 06/20/2013 | US20130156874 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
| 06/20/2013 | US20130156867 Artificial Tear Emulsion |
| 06/20/2013 | US20130156854 Controlled Release Pharmaceutical Compositions of Milnacipran |
| 06/20/2013 | US20130156784 Compositions Using Antibodies Directed To GPNMB And Uses Thereof |
| 06/20/2013 | US20130156781 Anti-dr4 agonist antibodies |
| 06/20/2013 | US20130156780 Annexin 1 Antibody |
| 06/20/2013 | US20130156778 Dendritic cell inhibitory proteins from ticks |
| 06/20/2013 | US20130156763 ILT3 Polypeptides and Uses Thereof |
| 06/20/2013 | US20130156757 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 06/20/2013 | US20130156732 Antiviral compounds |
| 06/20/2013 | US20130156731 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
| 06/20/2013 | US20130156727 Indole derivatives as inhibitors of histone deacetylase |
| 06/20/2013 | US20130156725 Random pentapolymer for treatment of autoimmune diseases |
| 06/20/2013 | US20130156720 Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| 06/20/2013 | US20130156712 Stable surfactant compositions for suspending components |
| 06/20/2013 | US20130156710 Cyclohexyl carbamate compounds as skin and/or hair lightening actives |
| 06/20/2013 | US20130156704 Therapy for subarachnoid hemorrhage and ischemia |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/19/2013 | EP2604266A1 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 06/19/2013 | EP2604262A1 Composition comprising a reduced isoalpha acid, a mineral and a vitamin for use in the treatment of autoimmune diseases |
| 06/19/2013 | EP2604257A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 06/19/2013 | EP2603501A1 Heterocyclic antiviral compounds |
| 06/19/2013 | EP2603239A2 Neuropilin as a biomarker for bevacizumab combination therapies |
| 06/19/2013 | EP2603229A1 Galvinoxyl derivative for use thereof against lipoprotein-enveloped viruses, in particular herpesviruses |
| 06/19/2013 | EP2603222A1 Combinatory cancer treatment |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN103157111A New combinaition and pharmaceutical compositions containing same |
| 06/19/2013 | CN103157110A Application of aromatase inhibitor in preparation of anti-cirrhosis or anti-liver fibrosis drugs |
| 06/19/2013 | CN103156818A Production process for nsaid-containing lozenges, their compositions, their medicinal use |
| 06/19/2013 | CN102698272B Medicinal composition for preventing diabetes, and application thereof |
| 06/19/2013 | CN102698271B Hypoglycemic drug composition and application thereof |
| 06/19/2013 | CN101627027B 氨基吡唑激酶抑制剂 Aminopyrazole kinase inhibitors |
| 06/19/2013 | CN101466835B Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466116 Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
| 06/18/2013 | US8465753 Combination vaccines against Mycobacterium sp. and methods of using the same |
| 06/18/2013 | US8464711 Methods for treating headaches |